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 Objective. Assess the workforce and workplace for rheumatology, 
and the investigative work of early career rheumatologists. 
Methods. Early career rheumatologists were defined as practicing 
physicians that joined the American College of Rheumatology 
(ACR) in 1991-2005, were 49 years of age or younger on joining, 
and resided in North America. This cohort participated in a Web-
based survey distributed by ACR. A total of 247 survey 
instruments (21.2 % response) were used for this analysis. 
Survey questions were designed to obtain core insights about: 
the workforce, workplace, investigative activities, funding, and 
demographic profile. 
Results. Respondents from all workplaces---clinical, academic, 
federal, industrial---engaged in clinical care, teaching, 
administration, and research. The time devoted to these tasks 
was employer dependent, and workplaces shaped the scale and 
scope of research. Patient-oriented research was predominant 
across all workplaces. Disease-, population-, and translational- 
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research was intermediate, and few respondents pursued basic- or 
prevention-oriented research in any workplace. Rheumatologists 
obtained extramural (21.3 %) and intramural (78.7 %) funds to 
pay portions of their salaries for time spent on research. 
Receiving an NIH K08/K23 award was associated with receiving 
federal research-project grants (P < 0.001). Respondents 
associated investigative work with reduced earnings, a 
perception validated by an estimated drop in pre-tax annual 
earnings of 2.3% for each half-day/wk dedicated to research (P < 
0.01). 
Conclusions. The results justify interventions for closing gaps 
embedded in investigational rheumatology. These include: 
improved funding for clinical research, increasing the number of 
K08/K23 awards; and recruiting rheumatologists from 
underrepresented demographic groups. 
 
 
 
 
     Clinical research commands a pivotal position in the 
overall structure of medicine for several reasons. First, and 
foremost, clinical investigation is the proving ground for all 
innovations and discoveries that advance the practice of 
medicine. Second, clinical research serves as the training 
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ground for producing the next generation of investigators needed 
to sustain medical progress. Third, a reward structure has 
evolved among clinical investigators leading to peer 
recognition, and the opportunity to obtain funds required for 
the production of a public good. In the case of rheumatologists, 
clinical investigation serves as the mechanism to advance 
clinical practice through the development of improved 
diagnostics, new treatments, and preventions that enhance the 
lives of the thousands of patients that suffer from a disorder 
occasioned by persistent pain and accumulated disability (1). 
     The scope and scale of clinical research is unknown for any 
medical or surgical specialty beyond snapshots of the broad aims 
and expenditures of research programs sponsored by federal 
agencies or the pharmaceutical industry (2-4). As a consequence, 
the workforce and workplace for clinical investigation is 
enigmatic and unexamined even after explicit warnings that an 
essential arm for advancing clinical practice has been disabled 
(5-8). The present study was designed to assess the workforce 
and workplace for rheumatology, and the extent and type of 
research prevailing among rheumatologists early in their 
careers. Our findings provide fresh insights about the workforce 
and the workplace for rheumatology, and justify interventions to 
address gaps in both the scope and scale of clinical research in 
arthritis and rheumatism. 
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MATERIALS AND METHODS 
     Survey participants. The ACR is the primary professional 
organization dedicated to advancing the practice of rheumatology 
in North America. An agreement was made with the ACR to 
distribute a Web-based questionnaire, produced by the authors, 
to member's email addresses. A letter of invitation from the ACR 
preceded respondent access to the survey instrument. 
     Rheumatologists, early in their careers, were identified 
based on five criteria: joined ACR between January 1, 1991 and 
December 31, 2005, earned an MD or equivalent degree, held an 
active license to practice medicine, resided in Canada or the 
US, and were 49 yr of age or younger on joining ACR. These 
criteria were adopted to assess physicians that complete 
fellowship training at a mean age of 34 yr, obtain support for 
their first research project grant at a mean age of 44.2 yr if 
they compete for federal grants/contracts, and function as 
principal investigator (PI) or co-principal investigator (Co-PI) 
for at least 5 yr (9).  
     Prospective respondents received an original email, and two 
follow-up email reminders if they failed to return a survey 
questionnaire between December 2007 and February 2008. The 
survey tool is available at 
<http://www.cornellsurveyresearch.com/sri/files/Rheumatology_Que
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stionnaire.pdf>. A total of 265 rheumatologists responded to 
this study. Incomplete surveys were discarded making 247 
questionnaires available for analysis, yielding a final response 
of 21.2 %. The survey protocol adopted for this study was 
consistent with that used by the ACR to survey members about 
services or issues affecting the practice of rheumatology.  The 
mean response for three ACR surveys performed in 2007-2008 was 
25.7 % (10), a value approximating the response rate achieved 
here. 
     Participant instructions noted that the Board of Directors 
of ACR approved the survey, and that IRB approval was obtained, 
for an exempt protocol, from the Office for the Protection of 
Research Subjects, University of Illinois at Chicago, Chicago, 
IL. Respondents were advised that participation was voluntary, 
confidentiality would be maintained, and that none of the 
research conducted or published would divulge the responses of 
individual physicians. Questionnaires were submitted anonymously 
over the Internet. Survey security was maintained by using 
secure servers to direct participant responses over the Internet 
and store data. 
       Design of survey instrument. A preliminary version of the 
survey questionnaire was tested for ambiguity and errors. A 
random sample of 50 rheumatologists, satisfying all early career 
criteria, was asked to respond to a prototype questionnaire. 
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Pilot survey participants were instructed to provide written 
comments on any question that was ambiguous, awkward, or 
impertinent. A total of 18 participants returned questionnaires 
used to reformat the survey. The responses of pilot survey 
participants were excluded from this report. 
      The final version of the survey questionnaire asked 
participants to identify their employment sector, designate the 
half-days/wk spent on administration, clinical care, teaching, 
and research, specify the source(s) of salary support for time 
spent on research, and indicate their annual pre-tax 
compensation within ordered ranges. Respondents were asked to 
specify one or more types of research that typified their 
investigative activities over the past 12 months. Clinical 
research was defined to be inclusive, embrace the 
recommendations of a consensus development conference convened 
to codify clinical investigation, and respect definitions 
adopted by others (6, 11,12).  
     A series of positive and negative questions were used to 
examine the basis for incentives and disincentives for pursuing 
investigative careers. Questions relied on a 4-point Likert 
scale (13) that was collapsed to consider two outcomes: agree or 
disagree. A second set of questions considered institutional 
support for research during residency and fellowship training, 
extramural funding for post-fellowship training in research, and 
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the receipt of extra- and/or intra-mural funds for research 
projects as a PI or Co-PI. The last question set considered 
respondent age, citizenship (Canada or US), gender, and ethnic 
background. The ethnic background of individuals graduating from 
allopathic schools of medicine in the US was estimated by 
calculating the mean distribution of ethnic groups graduating in 
1991-2005 (14).  
Data analysis. A unique, computer generated, case number was 
assigned to each questionnaire to respect respondent 
confidentiality throughout this study. Statistical assessments 
were made with software produced by Stata (version 6.0, Stata, 
College Station, TX). Pearson’s chi-square goodness-of-fit-test 
was used to determine whether the cohort of survey respondents 
differed from the population of prospective participants. 
Results involving multiple comparisons among groups relied on 
testing whether distributions differed across groups or in the 
case of means whether the means differed between or among 
groups. Data involving frequency statistics, such as yes/no 
responses and the distribution of women/men, were compared via 
Pearson’s chi-square goodness-of-fit-test. Statistical 
assessments involving means relied on the analysis of variance, 
or a simple paired T-test for between group comparisons. 
     A multiple regression model was used to test the 
association between the receipt of grants by PI's and Co-PI's. 
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Probability estimates of regression coefficients assumed that 
tested variables were distributed randomly. Assumptions 
underling the unmodified ordinary least squares model included: 
linearity, full rank, exogeneity of independent variables, 
homoscedasticity of error terms, and exogenously generated data. 
Results are reported as two-sided P-values. 
      A Tobit regression model was used to determine the 
association between pre-tax annual earnings and various outcome 
measures to accommodate the censored earnings that respondents 
reported within specified ranges. We tested dependent variables, 
with binary responses, using the logit regression model with the 
assumption that the natural log of the probability ratio is 
approximated by a linear function. Certain respondents failed to 
report the number of half-days spent on research, or provide 
information related to the submission of proposals for research 
project grants. The absence of a response, in a few cases, is 
assumed to be zero or identical to the no-responses entered by 
most respondents. This transformation was based on the 
assumption that rheumatologists who are uninvolved in research 
would likely overlook the need to document a zero response. 
RESULTS 
 
      Respondent sample. The cohort of prospective participants 
was compared with the respondent sample to test whether or not 
the two populations differed on the basis of gender mix, age 
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distribution, location of states within the US, and country of 
residence. The tested criteria were similar in both populations 
(P > 0.20), an indication that the 247 survey participants were 
representative of ACR members early in their careers. 
     Respondent profile. A respective 10.5 % and 19.9 % of 
respondents earned baccalaureate and MD (or equivalent) degrees 
outside of North America. Residency and fellowship training was 
accomplished in North America by 98.6% of respondents.  
     Respondents completed medical school at 27.1 ± 0.2 years of 
age (mean ± SEM) and finished fellowship training at 33.7 ± 0.2 
years of age (mean ± SEM), an elapsed interval of 6.6 ± 0.2 
years (mean ± SEM). Women and men completed pre-and post-
clinical training at similar ages (P > 0.25). Over 99% of the 
respondents reported they were board-certified or board-eligible 
in either adult or pediatric rheumatology, an indication that 
respondent training was consistent across these two related 
subspecialties. 
     Most respondents resided in the US (95 %) and the remainder 
in Canada (5 %). The mean fraction of citizens, permanent 
residents, and non-citizens from the US was 85.8 %, 8.5 %, and 
5.7 %, respectively. The fraction of citizens, permanent 
residents, and non-citizens among 
Canadian rheumatologists were similar to those of 
rheumatologists from the US (P > 0.50). The gender mix of early 
 11
career participants from the US was 44.8 % women and 55.2 % men. 
Respondent data, from both countries, were merged into a single 
data set since no significant differences (P > 0.50) were 
evident in any demographic measure (age, gender, ethnic 
background).  
    The self-identified ethnic backgrounds of rheumatologists 
from the US were compared with graduates of allopathic schools 
of medicine (Table 1). The distribution of respondents from 
Asian and Hispanic/Latino backgrounds approached that of US 
graduates (Table 1). The number of Black or African American 
rheumatologists, in contrast, was underrepresented in this 
survey sample by 6.5% while the number of Caucasians was 
overrepresented by a similar amount when compared with the 
cohort of individuals earning an MD degree in 1991 to 2005 
(Table 1). 
     Workplace assessment. The time devoted to clinical service, 
teaching, research, and administration was estimated by asking 
respondents to specify the half-days/wk committed to these 
activities (Table 2). Clinical care was accomplished across all 
workplaces. Respondents employed in a solo or group practice, or 
health system, spent 7.9 half-days/wk on clinical service, a 
commitment exceeding that of other workplaces (P < 0.05). In 
contrast to providers, respondents employed by academic medical 
centers/teaching hospitals (AMCs), federal government, and 
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pharmaceutical/biotech industry worked a respective 3.5, 2.3 and 
1.5 half-days/wk on clinical service (Table 2). 
     Rheumatologists from all workplaces participated in 
teaching medical students, residents, or fellows (Table 2). 
Academic respondents devoted 1.3 half-days/wk to teaching 
whereas providers, federal employees, and those from industry 
spent 0.4, 0.6 and 0.5 half days/wk, respectively, which was 
significantly less (P < 0.01) than academics (Table 2). Clinical 
care providers spent 1.4 half-days/wk conducting research. 
Respondents from AMC's reported dedicating 4.0  half days/wk to 
research, while those in the federal and pharmaceutical/biotech 
sectors spent a respective 4.8 and 5.1 half days/wk (Table 2). 
Administrative work, including committee responsibilities, 
involved 0.8 half days/wk among providers, 1.5 half days/wk in 
academic and federal workplaces, and 3.8 half days/wk in 
industry (Table 2). 
Scope and scale of research. The extent and type of research 
pursued by respondents was workplace dependent (Table 3). No 
gender disparities were evident, in any workplace, among the 
fraction of respondents involved or uninvolved in research or in 
the distribution of respondents pursuing basic and clinical 
research (P > 0.25). 
     In the clinical care workplace, 59.3 % of providers pursued 
research albeit at levels below workplaces providing dedicated 
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research time (Table 3). Patient-, disease-, and population-
oriented research involved a respective 36.4 %, 9.3 % and 6.8 % 
of providers. Providers pursued basic-, translational-, and 
prevention-oriented research, but the fraction of respondents 
was limited to 1.9 % to 3.1 % (Table 3).  
     The extent and type of research accomplished in federal and 
pharmaceutical workplaces was similar (P > 0.15). Academic 
respondents devoted analogous attention to patient-, disease-, 
and population-oriented research (P > 0.25) as indicated by 
respective commitments of 21.6 %, 19.5 %, and 19.5 %. Basic-, 
and translation-oriented research involved respective efforts of 
13.7 % and 11.6 %, while prevention research was limited to 4.2 
% (Table 3).  
      Analysis of the extra- and intra-mural funds used by 
respondents to defray a portion of their salaries for time spent 
of on research indicated no gender disparities (P > 0.25) were 
evident in extra- and intra-mural support available to women and 
men. Grants/contracts, from federal and nonfederal sources, 
supported the salaries of 21.3 % of respondents.  The remaining 
78.7 % of respondents relied on intramural funding to pay for 
research time. Intramural funds were derived from: clinical 
earnings (39.7 %), medical schools and/or hospitals (14.5 %), 
endowments/other sources (8.3 %), and the salaried commitments 
of federal (8.3 %) or pharmaceutical (7.9 %) employers.  
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     The proposals submitted and grants/contracts received by 
early career rheumatologists from the US indicated that 20.6 % 
of respondents applied for post-fellowship research training 
from federal and non-federal sources, and 13.1 % submitted 
applications for NIH K08/23 awards (Table 4). An average of 1.8 
proposals was required per K08/23 award with a success rate of 
41.1% per respondent or 22.2 % per application (Table 4). Fewer 
training proposals were submitted to the VA in comparison to 
NIH, but with comparable success rates (Table 4). The receipt of 
an NIH K08/23 award was a consequential marker of research 
project grants awarded to PI's and Co-PI's (P < 0.001). 
Specifically, rheumatologists receiving a K-award were estimated 
to receive an average of 2.8 and 1.2 federal research project 
grants as respective PI's or Co-PI's. The association between 
the receipt of K-award and the subsequent receipt of a research 
project grant was independent of gender (P < 0.01). Women and 
men recipients of K-awards were just as likely to receive NIH 
R01 awards. 
     Respondents, from the US, produced 319 proposals as PI's or 
Co-PI's (Table 4). Prospective PI's submitted an average of 2.8 
research project proposals to NIH, and received 2.0 awards for a 
success rate of 51.1 % per respondent or 31.1% per proposal 
(Table 4).  Fewer proposals were submitted to non-NIH HHS 
agencies and the VA, but respondent success exceeded (P < 0.05) 
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that for NIH awards (Table 4). The success of investigator-
initiated proposals considered by philanthropy, industry, and 
other funding sources was a respective 42 %, 43%, and 50% (Table 
4). Proposals submitted by Co-PI's were funded on the same order 
(P > 0.15) as those of PI's (Table 4). 
 Individual and institutional commitments to research. 
Respondents were queried about their interest in pursuing 
investigative careers as medical students, residents, and 
fellows. The fraction of positive responses (yes) increased from 
28.7 % for medical students, 38.6 % for residents, and 60.3 % 
for fellows. The same cohort was asked to indicate whether they 
were aware of opportunities to participate in faculty-mentored 
research projects. Only 22.7 % of medical students and 25.5 % of 
residents reported being aware of such opportunities, whereas 
67.6 % fellows acknowledged the possibility of participating in 
faculty-sponsored research. Potential deterrents to pursuing a 
research career were examined to identify interventions that can 
enhance the workforce for investigative rheumatology. The time 
and energy required for a meaningful research career was not 
considered to be more demanding than that required for a similar 
career involving clinical service (P > 0.25).  
     Rheumatologists (72.4 %) viewed job uncertainty as a 
significant concern for clinical investigators relative to 
providers (P < 0.01). Respondents (75.6 %) perceived that the 
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earnings of clinical investigators were less than those of 
providers (P < 0.01). This perception was tested by using a 
Tobit regression model specifying the natural logarithm of pre-
tax annual earnings as a function of two key explanatory 
variables – years post fellowship and half-days/week devoted to 
research – as well as variables to control for gender, 
employment sector, and total work hours per week. The results 
indicate that pre-tax annual earnings increased linearly at 1.8 
% per year of post-fellowship experience (Fig. 1A). However, the 
earnings of rheumatologists devoting two or more half-days/wk to 
investigative work fell by 2.3 % per year for each half-day/wk 
spent on research (P < 0.01) relative to individuals spending 
one half-day/wk or less on investigative work (Fig.1B). 
     Institutional support for early career academics was 
estimated by using the total dollar value of start-up packages 
provided for personnel, equipment, supplies, and other research 
expenses. Investment in the research programs of early career 
academic rheumatologists increased linearly with the number of 
half-days/wk devoted to research (Fig. 1C). 
DISCUSSION 
     The present study provides important new insights about the 
workforce and workplace for rheumatology, and extends knowledge 
about the extent and type of research accomplished by 
rheumatologists early in their careers. The findings rely on 
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self-reported responses to a Web-based questionnaire to assess 
the administrative, clinical, didactic, and investigative work 
of rheumatologists affiliated with academic, clinical, federal, 
and industrial employers. The results fill a gap occasioned by 
the lack of a national protocol for appraising clinical 
investigation and its practitioners. Our report establishes a 
template for estimating the scope and scale of clinical research 
within medical subspecialties, and the assessment of explanatory 
variables---categorical and continuous---that inform policy and 
furnish a rational framework for interventions enhancing 
innovation and discovery in investigative rheumatology. 
     The analysis of administrative, clinical, didactic, and 
investigative work established that the time devoted to these 
tasks is workplace dependent (Table 2). The novel aspect of this 
assessment involves the dissection of workplaces based on the 
extent and type of research pursued by early career 
rheumatologists. Research, of all types---basic-, translational-
, disease-, patient-, population-, prevention---was accomplished 
by academic, federal, industrial, and provider workforces. 
However, the results show that the scope and scale of research 
is a hallmark of the workplace (Table 3). The provider 
workplace, for example, emphasized patient-oriented studies, a 
focus exceeding all other research endeavors by four- to five-
fold. Providers may direct or participate in various clinical 
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protocols, including registries, cohort studies, and multicenter 
clinical trials of new drugs (Table 3). While the survey did not 
distinguish among these possibilities, it seems likely that most 
provider research involved patient enrollment in protocols 
developed and funded by industrial or federal sponsors since 
provider research time was restricted to 15.3 % of their total 
professional effort (Table 2). Certain rheumatologists in 
private practice, however, are known to participate in 
registries and other prospective cohort studies. 
     Rheumatologists employed in federal and pharmaceutical 
workplaces devoted more time to research than any other 
activity, and the distribution of investigative approaches was 
similar in both workplaces (Table 3). The minor distinction 
between the two workplaces pivoted on translational research in 
the pharmaceutical industry, an investigative emphasis exceeding 
that of all other workplaces. Research in the academic workplace 
was dispersed among multiple investigative activities. The 
diversity of investigative pursuits within the academic 
workplace contrasts with the focal specificity of research in 
other workplaces.  
     Prevention-oriented research, however, emerged as an orphan 
enterprise across all workplaces considered here. Stakeholders 
should consider this void as a singular opportunity to plan 
interventions aimed at promoting prevention research among early 
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career rheumatologists. Such research would provide a platform 
to establish an individual’s risk for developing disease, 
provide protocols to prevent disease onset, and make it possible 
to intervene at the earliest possible time when disease occurs 
(15-17). Adoption of such a paradigm would begin the 
transformation of rheumatology from a curative to a preventative 
focus with personal health care planning (15). 
     Analysis of the proposals produced by respondents for 
research grants/contracts provided new information about 
rheumatologists receiving K08/23 awards. We observed a 
compelling association (P < 0.001) between recipients of K08/23 
awards and the subsequent award of an estimated 2.8 NIH research 
project grants. While the survey questionnaire did not control 
for all possible variables needed to predict the success of K-
awardees as future recipients of federal research grants, the 
unequivocal effectiveness of K-awardees, observed here, provides 
the logic for proposing a modest increase in the number of 
K08/23 awardees to support approximately 8 % of the 240 
individuals that complete fellowship training in adult or 
pediatric rheumatology each year (18).  
     The present assessment of the academic workforce indicates 
that investigative rheumatology is hobbled at multiple levels. 
First, investigative work is highly leveraged on intramural 
funds as opposed to extramural grants/contracts. This assertion 
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stems from finding that almost 80 % of academic rheumatologists 
relied on intramural funds to cover a portion of their salary 
for time spent on research. Clinical earnings were used to 
generate about 40 % of the intramural funds used by early career 
academics or almost twice the support derived from extramural 
grants/contracts. Next, the time available for research was 
limited by the need to accomplish service-related tasks among 
early career academics. Finally, less that 6 % of academics 
received an NIH K08/23 award for post-fellowship research 
training (Table 4). Beyond this set of workforce constraints 
resides a host of limitations tied to an ailing and outmoded 
national infrastructure for sustaining clinical research (11, 
19). For instance, a disparity approaching 2:1 prevails for 
funding basic versus clinical research by federal agencies (20-
21), and a recent report documents the difficulty of funding 
clinical research and population-based studies by individual 
institutes within NIH (22). The summed constraints in both the 
workforce and federal-institutional partnership prompts the 
suggestion that stakeholders in rheumatology---academic, 
federal, industrial, philanthropic, professional---pursue 
interventions for the gradual systematic growth of clinical 
research in rheumatology. The intent of this proposal is to 
enlarge the fraction of rheumatologists with research training 
(K-awardees) so they can subsequently gain extramural research 
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support for research project grants, and have the time and 
funding to advance the clinical practice in rheumatology.  
     Consideration of the deterrents for pursuing investigative 
careers indicated that 75.6 % of respondents perceived that 
providers held an earnings advantage over clinical 
investigators. This perception was verified by showing that pre-
tax annual earnings fell by 2.3 % for each half-day/wk devoted 
to investigative work among rheumatologists spending 2 or more 
half-days/wk on research (Fig 1B). The observed disparity in 
annual earnings does not reflect the presumed remuneration to 
mid-career and established researchers that went undetected 
because this study focused on early career investigators. 
Clinical investigation, moreover, remains the source of non-
monetary rewards, including: peer recognition for innovation and 
discovery, the opportunity to obtain extramural funds for the 
production of a public good, and the self-satisfaction of 
championing advances in clinical practice. The significance of a 
"research cohort" to rheumatology far outweighs their number in 
the clinical workforce since a single innovation offers the 
potential to benefit thousands of patients by transforming the 
clinical management of a particular condition (23). 
     The assessment of self-identified ethnic backgrounds 
identified a gap in the fraction of Black or African American 
respondents within the workforce for rheumatology (Table 1). The 
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under representation of rheumatologists, from any demographic 
background, is of intrinsic importance to investigative 
rheumatology because the ethnic profile of volunteers agreeing 
to participate in a clinical trial reflects the ethnic 
background of physicians directing the study (24). Reliable 
estimates of the safety/efficacy of new drugs or treatments are 
unachievable unless the participants in a clinical study 
approximate the demographic profile of the US population (25-
26). Disparities in the ethnic backgrounds of practicing 
physicians point to the need to pursue interventions designed to 
recruit future generations of rheumatologists that mirror the 
demographic norms of graduates from allopathic schools of 
medicine in the US (14, 27-29). 
     The present study is based on a limited number of survey 
participants. Responder participation in this survey, however, 
was consistent with that of other surveys accomplished by the 
ACR. Further, statistical comparisons of responders and non-
responders established that both cohorts were similar (P > 0.25) 
based on gender mix, age distribution, residency within states 
in the US, and country. Finally, the demographic profile of 
survey respondents conforms to data reported in the annual 
survey of graduate medical education for rheumatologists (18), 
and data on the workforce for rheumatology (30). Despite this 
evidence, the results should be viewed as an indicator rather 
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than absolute measure of the workforce, workplace and the 
research accomplished by early career rheumatologists.  
     In conclusion, this study calls attention to multiple 
issues limiting advances in investigative rheumatology. The 
findings provide stakeholders---academic, federal, industrial, 
philanthropic, professional---with an evidence-based rationale 
to pursue multiple interventions for remodeling clinical 
research in rheumatology. The present results are not intended 
to detract from recent initiatives, championed by NIH, to 
improve the climate for clinical scholarship (31-33).  Instead, 
the findings compliment and extend the efforts made by NIH, and 
provide a rational framework to initiate a national dialog aimed 
at establishing a public and private infrastructure to support 
investigative rheumatology prudently and amply (34). Only then 
will a bright future be assured for innovation and discovery in 
rheumatology, and benefit patients debilitated by 
musculoskeletal diseases.  
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Table 1. Self-identified ethnic backgrounds of rheumatologists, early in their careers, and  
 
graduates of allopathic schools of medicine in the United States. 
 
Ethnic  
background 
      Self-identified backgrounds (mean %)*   Graduates of  
   US medical 
  schools (%)† 
   Women         Men              Both 
                           genders      
     
American Indian or 
Alaskan Native‡  
     ---        ---         ---           0.7 
     
Asian American     16.8        14.4                15.5         16.9 
     
Black or African 
American 
      0.9          0.0          0.4           6.5 
     
Caucasian     72.9       76.5        74.9         68.7 
     
Hispanic or Latino 
American 
      5.6         6.1          5.9           6.4 
     
Multiethnic       1.9         0.8          1.3    Unreported 
     
Other: unknown or 
unreported§ 
 
      1.9         2.3           2.1           0.8 
 
     
 
*Each value is expressed as the mean percent of responses reported by early career 
rheumatologists that consisted of 107 (44.8 %) women and 132 (55.2 %) men out of a total of 
239 eligible graduates of allopathic medical schools in the US. 
† The ethnic backgrounds of allopathic medical school graduates in the US was determined by 
estimating the mean number of individuals, within specified ethnic groups, that graduated from 
allopathic schools of medicine, each year, and from1991 to 2005 (14). An average of 15,713 
physicians graduated per year between 1991 and 2005, the same 15-year sample window adopted 
for the present survey of rheumatologists early in their careers. 
 31
‡ The number of American Indians and Alaskan Natives was not determined in this study, but 
are listed here to coincide with the demographic profiles of graduates from allopathic schools of 
medicine in the US (14). 
§ The fraction of individuals that self identified as "other" may include rheumatologists from 
ethnicities (American Indian, Alaskan Native, Hawaiian Native, Pacific Islander) that were 
unlisted in the survey instrument for this study, or it may consist of individuals whose ethnicity 
is unknown or undisclosed. 
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Table 2. Time committed to clinical service, teaching, research, and administration  
 
among workplaces employing early career rheumatologists. 
 
   Activity                           Time commitments in half-days/wk (mean ± SEM)* 
                                                               (percent effort) 
    Clinical 
    care 
providers† 
   AMC 
  teaching   
  hospital‡ 
     Federal§ 
HHS/DOD/VA 
 Pharmaceutical 
      
biotech/industry 
          
Clinical service  7.9 ± 0.2  
   (74.7) 
 3.5 ± 0.2        
   (34.9) 
     2.3 ± 0.4 
      (21.6) 
     1.5  ± 1.3 
       (13.6) 
          
Teaching¶  0.4 ± 0.1    
    (3.6) 
 1.3 ± 0.1 
   (11.9) 
     0.6 ± 0.2 
        (6.8) 
      0.5 ± 0.4 
        (4.5) 
          
Research  1.4 ± 0.1  
   (15.3) 
 4.1± 0.3 
  (38.7) 
     4.8 ± 0.9 
       (52.8) 
       5.1±0.9 
       (44.1) 
        
Administration∫  0.8 ± 0.1    
    (6.4) 
 1.5 ± 0.1 
  (14.5) 
     1.5 ± 0.3 
       (18.8) 
      3.8 ± 1.5 
       (37.8) 
     
  Totals 10.5 ± 0.1 10.4 ± 0.2      9.2 ± 0.3     10.9 ± 0.7 
 
* Each value is expressed as the mean ± standard error of half-days/wk reported by respondents 
for each of the designated activities. The numbers in parenthesis are expressed as the mean 
percent effort within each workplace to facilitate comparisons among workplaces. The results are 
based on 226 early career rheumatologists out of a total of 247 eligible respondents. The number 
of respondents employed in clinical care, AMC's, federal government and industry was 113, 96, 
10 and 7, respectively. Note some respondents did not qualify for inclusion in this data set 
because they were unaffiliated with one of the four employers designated here. 
     Respondents were asked to specify the half days/wk devoted to the indicated activities during 
the 12 mo the preceded the survey based on the time they negotiated with their supervisors. The 
results provide an estimate of the time/effort reported for a putative 40 hr workweek since 
respondents were advised to exclude "off-the-clock" commitments for activities accomplished 
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after normal working hours or on weekends, holidays or vacation periods. Note that the "total" 
half-days/wk deviate from the expected value of 10. Values were not normalized to 40 hr/wk to 
allow the data to reflect the actual time reported by respondents within each workplace.   
†Clinical care providers refer to early career rheumatologists who deliver clinical care as an 
owner/partner of a solo or group practice, or are employed by a group practice, health system, or 
hospital. 
‡AMC: academic medical center refers to any medical school or teaching hospital accredited to 
sponsor a residency program in internal medicine or pediatrics, or a fellowship program in adult 
or pediatric rheumatology or both as approved by the Accreditation Council for Graduate 
Medical Education <http://www.acgme.org>. 
§Federal government: includes any early career rheumatologist employed by the Department of 
Health and Human Services (HHS), Department of Defense (DOD), or the Department of 
Veterans Affairs (VA). 
¶Includes the total time devoted to all teaching: medical students, residents, or fellows. 
∫Includes the total time devoted to both administrative work and committee assignments. 
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Table 3. The effect of workplace on the type of investigative work accomplished by 
rheumatologists early in their careers. 
 
 
       Type of      
    investigative 
       activity 
                                     Workplace and/or employer (%)* 
  Clinical care    
     provider† 
         Federal      
     government‡ 
   HHS/DOD/VA 
  Pharmaceutical    
     or  biotech 
        industry 
     Academic  
      medical        
       center§ 
     
None        30.9            4.8           6.3           5.5 
     
Basic          2.2            9.5          12.5          14.4 
     
Translational          2.2            9.5          18.8          12.2 
     
Disease-oriented         10.8           23.8          18.8          20.4 
     
Patient-oriented         42.4           42.9          37.5          22.7 
     
Population-oriented           7.9             9.5            6.3          20.4 
     
Prevention-oriented           3.6               0             0            4.4 
     
 
* Each value is expressed as the mean percent of early career rheumatologists reporting a 
commitment to one or more of the investigative activities within designated workplaces. The 
results are based on 244 early career rheumatologists out of 247 eligible respondents. Note, 
respondents were allowed to specify one or more of the designated activities to reflect the type of 
investigative work pursued in the 12 mo preceding the survey. Investigative activities were 
defined using terminology adopted by others (6, 11-12), and appeared as follows in the survey 
tool: Basic research: laboratory-based research involving the development of new drugs, 
technologies, or devices. Translational research: bench to bedside or bi-directional research 
involving human subjects known to the investigator, excluding the use of human specimens 
(cells/tissues) for laboratory studies. 
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Disease-oriented research: requires use of human subjects to investigate the mechanisms or 
natural history of disease, or improve the detection or diagnosis of disease. Patient-oriented 
research: clinical trials, including Phase I, II, III, IV trials of drugs, biologics, devices, and the 
evaluation of therapeutic interventions. Population-oriented research: outcomes studies of 
populations, health services and cost effectiveness research, studies of health quality including 
best practices and medical errors, epidemiology and genetic studies, and community-based 
clinical trials. Prevention-oriented research: primary and secondary prevention of disease in 
patients, and health promotion via behavioral modification. 
† Clinical care providers refer to early career rheumatologists who deliver clinical services as an 
owner/partner of a solo or group practice, or are employed by a group practice, health system, or 
hospital. 
‡Federal government: includes all early career rheumatologists employed by the Department of 
Health and Human Services (HHS), Department of Defense (DOD), and the Department of 
Veterans Affairs (VA). 
§Academic medical centers refers to any medical school or teaching hospital accredited to 
sponsor a residency program in internal medicine or pediatrics, or a fellowship program in adult 
or pediatric rheumatology or both as approved by the Accreditation Council for Graduate 
Medical Education <http://www.acgme.org>. 
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Table 4. Analysis of proposals submitted and awards received by early career rheumatologists for post fellowship research  
 
training and research project grants. 
 
Type of proposal or   
      grant award 
                    Sources of funding available to early career  rheumatologists from the US 
                     HHS*        VA*       DOD* Philanthropy    Industry     Other 
        NIH†         Other HHS†         
                  
Training (post 
fellowship) 
              
   Proposals/respondent‡    1.8 ± 0.3          0    1.4 ± 0.2         0    1.8  ± 0.2    2.6 ± 0.8    1.6 ± 0.2 
                  
   Success/respondent (%)       41.2        ---       20.0        ---         NA§         NA         NA 
               
Research as PI               
   Proposals/respondent‡    2.8 ± 0.4    0.9 ± 0.5    1.1 ± 0.6    1.5 ± 0.5     2.7 ± 0.3    2.9 ± 0.5    1.8 ±  0.3 
               
   Grants /respondent‡    2.0 ± 0.3    1.3 ± 0.3    1.0 ± 0.1         0     2.4 ± 0.3    2.3 ± 0.4    2.0 ± 0.7 
               
   Success/respondent (%)       51.1      80.0       100         ---       42.2        43.8      50.0 
              
Research as Co-PI              
   Proposals/respondent‡   2.4 ± 0.4   1.1  ± 0.9         0        0    2.1  ± 0.6    2.3 ± 0.7    4.3 ± 2.3 
              
   Grants /respondent‡   1.9  ± 0.4   0.6 ±  0.5         0         0    1.4  ± 0.7    2.0 ± 0.7    1.7 ± 0.9 
              
   Success/respondent (%)      45.8      75.0         ---         ---       50.0       41.6       40.0 
 
* Federal departments: HHS-Department of Health and Human Services, VA-Veterans Affairs, and DOD-Department of Defense. 
† NIH- National Institutes of Health, Other HHS: AHRQ- Agency for Healthcare Research & Quality, CDC- Centers for Disease Control & 
Prevention FDA- Food & Drug Administration, HRSA- Health Resources & Services Administration, and SAMSA-Substance Abuse & Mental 
Health Services Administration. 
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‡ Each value is expressed as the mean ± the standard error of either the mean or the mean percent. Estimates of proposals submitted for post-
fellowship training are based on a cohort of 51 rheumatologists who produced 153 proposals from a sample of 239 eligible respondents. NIH 
post-fellowship data reflects K08/K23 proposals or awards.  
     Estimates of proposals submitted for research project grants by PI's are based on a cohort of 38 respondents that submitted 233 proposals 
from a sample of 239 eligible rheumatologists. Estimates of proposals submitted for research project grants by Co-PI's are based on a cohort of 
17 respondents who submitted 86 proposals from a sample of 239 eligible rheumatologists. 
§ NA: data not available.
Fig. 1A-top. The equation/linear function describes the relationship between the natural log of pre-tax 
annual earnings and years post fellowship for early career rheumatologists. The equation/linear 
function demonstrates that mean annual pre-tax earnings increased by 1.8 % per year for each year of 
post-fellowship experience. The equation/linear function is based on a Tobit regression model that 
controlled for gender, total work time/wk, half-days/wk spent on research, and for bias occasioned by 
the non-reporting of some variables as noted in the Material and Methods.  
Fig. 1B-middle. The equation/linear function describes the relationship between the natural log of pre-
tax annual earnings and half-days/wk devoted to investigative work among early career 
rheumatologists. The equation/linear function indicates that mean annual pre-tax earnings decrease by 
2.3% for each half day/wk spent on investigative work among early career clinical endocrinologists 
that spend two or more half-days/wk on research. The equation is based on a Tobit regression model 
that controlled for gender, total work time/wk, half-days/wk spent on research, and for bias occasioned 
by the non-reporting of some variables as noted in the Material and Methods.  
Fig. 1C-bottom. Each bar designates the mean ± standard error of the mean of constant dollars invested 
in junior faculty as a function of the number of half-days/wk respondents spent on research. 
Institutional investments were based on the mean value of start-up packages (total institutional dollars 
[corrected to constant dollars] for personnel, equipment, supplies, and other research expenses) 
provided to early career rheumatologists employed at AMC's. 
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